Published in CA Cancer J Clin on December 09, 2002
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin (2012) 5.58
Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst (2011) 4.59
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ (2009) 4.18
Health and economic implications of HPV vaccination in the United States. N Engl J Med (2008) 3.81
Evidence-based clinical guidelines for immigrants and refugees. CMAJ (2010) 3.57
Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination. J Natl Cancer Inst (2008) 3.33
Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ (2009) 3.20
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis (2012) 3.15
Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol (2008) 2.51
A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis (2013) 2.08
Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women. J Low Genit Tract Dis (2010) 2.03
Organizational factors and the cancer screening process. J Natl Cancer Inst Monogr (2010) 1.84
A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol Biomarkers Prev (2011) 1.82
Geographic disparity, area poverty, and human papillomavirus vaccination. Am J Prev Med (2010) 1.74
The frequency of Pap smear screening in the United States. J Gen Intern Med (2004) 1.70
Management of low-grade cervical lesions in young women. CMAJ (2005) 1.69
Modeling cervical cancer prevention in developed countries. Vaccine (2008) 1.61
Cervical cancer screening among women who gave birth in the US-Mexico border region, 2005: the Brownsville-Matamoros Sister City Project for Women's Health. Prev Chronic Dis (2008) 1.49
Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol (2009) 1.41
Statement on HPV DNA test utilization. Diagn Cytopathol (2009) 1.39
Estimation of newborn risk for child or adolescent obesity: lessons from longitudinal birth cohorts. PLoS One (2012) 1.35
Cervical cancer screening in the United States and the Netherlands: a tale of two countries. Milbank Q (2012) 1.35
Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers. Prev Med (2013) 1.33
A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J Biol Chem (2006) 1.30
Clinical decision support with automated text processing for cervical cancer screening. J Am Med Inform Assoc (2012) 1.30
Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. Ann Intern Med (2009) 1.29
Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping. J Clin Microbiol (2009) 1.29
The effect of access and satisfaction on regular mammogram and Papanicolaou test screening in a multiethnic population. Med Care (2004) 1.26
Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer. J Clin Microbiol (2010) 1.25
Development of an HPV educational protocol for adolescents. J Pediatr Adolesc Gynecol (2007) 1.24
Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers. Prev Med (2013) 1.22
Evaluation of a cervical cancer control intervention using lay health workers for Vietnamese American women. Am J Public Health (2010) 1.20
Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer. J Clin Microbiol (2010) 1.19
The impact of cervical cancer education for deaf women using a video educational tool employing American sign language, open captioning, and graphics. J Cancer Educ (2009) 1.18
Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol (2009) 1.16
A very rare case of HPV-53-related cervical cancer, in a 79-year-old woman with a previous history of negative Pap cytology. Clin Interv Aging (2014) 1.16
A community-based randomized trial of a faith-placed intervention to reduce cervical cancer burden in Appalachia. Prev Med (2012) 1.12
The vicious cycle of inadequate early detection: a complementary study on barriers to cervical cancer screening among middle-aged and older women. Prev Chronic Dis (2007) 1.12
Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey. Cancer (2011) 1.12
Cancer screening practices among physicians in the national breast and cervical cancer early detection program. J Womens Health (Larchmt) (2011) 1.11
Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine (2011) 1.10
Cervical cancer control research in Vietnamese American communities. Cancer Epidemiol Biomarkers Prev (2008) 1.09
A population-based evaluation of cervical screening in the United States: 2008-2011. Cancer Epidemiol Biomarkers Prev (2013) 1.08
Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer (2004) 1.08
Update on prevention and screening of cervical cancer. World J Clin Oncol (2014) 1.07
Abnormalities of uterine cervix in women with inflammatory bowel disease. World J Gastroenterol (2006) 1.04
Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women. J Gen Intern Med (2008) 1.03
Evaluation of a new DNA test for detection of carcinogenic human papillomavirus. J Clin Microbiol (2011) 1.02
Association of insurance status and age with cervical cancer stage at diagnosis: National Cancer Database, 2000-2007. Am J Public Health (2012) 1.02
Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol (2010) 1.01
Effect of cervical cytologic status on the association between human papillomavirus type 16 DNA load and the risk of cervical intraepithelial neoplasia grade 3. J Infect Dis (2008) 1.01
Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years. Br J Cancer (2014) 1.00
The costs of reducing loss to follow-up in South African cervical cancer screening. Cost Eff Resour Alloc (2005) 0.99
Impact of health education intervention on knowledge and perception of cervical cancer and cervical screening uptake among adult women in rural communities in Nigeria. BMC Public Health (2014) 0.98
Use of electronic health record data to evaluate overuse of cervical cancer screening. J Am Med Inform Assoc (2012) 0.96
Pap testing among Vietnamese women: health care system and physician factors. J Community Health (2004) 0.96
Cervical cancer screening among HIV-positive women. Retrospective cohort study from a tertiary care HIV clinic. Can Fam Physician (2010) 0.95
The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Gynecol Oncol (2009) 0.95
Pap smear receipt among Vietnamese immigrants: the importance of health care factors. Ethn Health (2009) 0.94
Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico. BMC Med Inform Decis Mak (2012) 0.92
Health locus of control and assimilation of cervical cancer information in Deaf women. J Cancer Educ (2010) 0.92
Formative evaluation of the accuracy of a clinical decision support system for cervical cancer screening. J Am Med Inform Assoc (2013) 0.92
An overview of prevention and early detection of cervical cancers. Indian J Med Paediatr Oncol (2011) 0.90
Integrating cervical cancer screening with HIV care in a district hospital in Abuja, Nigeria. Niger Med J (2013) 0.89
Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention. Infect Agent Cancer (2008) 0.89
Competency-based learning: the impact of targeted resident education and feedback on Pap smear adequacy rates. J Gen Intern Med (2004) 0.87
Overuse of papanicolaou testing among older women and among women without a cervix. JAMA Intern Med (2014) 0.87
Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds. Patient Educ Couns (2012) 0.87
Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action. J Oncol (2012) 0.87
Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management. Int J Cancer (2014) 0.87
Management of Papanicolaou test results that lack endocervical cells. CMAJ (2011) 0.86
Ending cervical cancer screening: attitudes and beliefs from ethnically diverse older women. Am J Obstet Gynecol (2008) 0.86
Association between physician specialty and uptake of new medical technologies: HPV tests in Florida Medicaid. J Gen Intern Med (2010) 0.86
Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents. J Adolesc Health (2008) 0.85
The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women. Cancer Causes Control (2015) 0.85
Analysis of genetic copy number changes in cervical disease progression. BMC Cancer (2010) 0.85
The challenging pelvic examination. J Gen Intern Med (2011) 0.85
Cervical neoplasia-related factors and decreased prevalence of uterine fibroids among a cohort of African American women. Fertil Steril (2013) 0.84
Cervical Cancer Screening Among Adult Women in China, 2010. Oncologist (2015) 0.83
Adolescent medicine: attitudes, training, and experience of pediatric, family medicine, and obstetric-gynecology residents. Yale J Biol Med (2009) 0.83
Significance of HPV-58 infection in women who are HPV-positive, cytology-negative and living in a country with a high prevalence of HPV-58 infection. PLoS One (2013) 0.83
How does public policy impact cervical screening and vaccination strategies? Gynecol Oncol (2010) 0.83
Racial and ethnic differences in personal cervical cancer screening amongst post-graduate physicians: results from a cross-sectional survey. BMC Public Health (2008) 0.83
Management of adolescents who have abnormal cytology and histology. Obstet Gynecol Clin North Am (2008) 0.83
HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease. Curr Obstet Gynecol Rep (2013) 0.82
Cervical Cancer Screening Service Uptake and Associated Factors among Age Eligible Women in Mekelle Zone, Northern Ethiopia, 2015: A Community Based Study Using Health Belief Model. PLoS One (2016) 0.82
Effects of direct-to-consumer advertising and clinical guidelines on appropriate use of human papillomavirus DNA tests. Med Care (2011) 0.82
Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies. Am J Obstet Gynecol (2014) 0.82
Towards early detection of cervical cancer: Fractal dimension of AFM images of human cervical epithelial cells at different stages of progression to cancer. Nanomedicine (2015) 0.82
Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies. Gend Med (2012) 0.81
Changes to cervical cancer prevention guidelines: effects on screening among U.S. women ages 15-29. Prev Med (2012) 0.81
Comparison of the DiagCor GenoFlow Human Papillomavirus Array Test and Roche Linear Array HPV Genotyping Test. Open Virol J (2010) 0.81
Clinical significance of human papillomavirus genotyping. J Gynecol Oncol (2016) 0.80
Family planning provider referral, facilitation behavior, and patient follow-up for abnormal Pap smears. Public Health Rep (2009) 0.80
Human papillomavirus disease and vaccines in adolescents. Adolesc Med State Art Rev (2010) 0.80
miR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a. Int J Clin Exp Pathol (2015) 0.80
Review of HIV-Related Cytopathology. Patholog Res Int (2011) 0.79
Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results. Gynecol Oncol (2013) 0.79
Cervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007. Cancer (2015) 0.78
Quality of care and health-related quality of life of climacteric stage women cared for in family medicine clinics in Mexico. Health Qual Life Outcomes (2010) 0.78
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst (2005) 7.70
American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin (2010) 6.45
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA (2015) 6.38
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol (2007) 6.25
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. Cancer Prev Res (Phila) (2010) 5.81
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin (2012) 5.58
Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet (2003) 5.40
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol (2013) 5.40
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology (2011) 5.17
Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen (2010) 4.72
The carcinogenicity of human papillomavirus types reflects viral evolution. Virology (2005) 4.72
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA (2007) 4.66
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin (2003) 4.43
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2012) 4.42
Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin (2007) 4.09
Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst (2010) 3.95
Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst (2011) 3.92
Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol (2004) 3.67
Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin (2006) 3.67
Supplemental oxygen impairs detection of hypoventilation by pulse oximetry. Chest (2004) 3.55
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol (2012) 3.51
American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin (2006) 3.46
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst (2008) 3.32
Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med (2003) 3.26
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine (2008) 3.17
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis (2012) 3.15
2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis (2007) 3.11
Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol (2006) 3.08
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis (2013) 3.06
A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med (2005) 3.01
2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol (2007) 2.97
American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin (2002) 2.94
The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. Am J Clin Pathol (2007) 2.91
American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin (2003) 2.91
Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation (2004) 2.91
The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer (2002) 2.85
Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol (2011) 2.85
The efficacy and safety of pain management before and after implementation of hospital-wide pain management standards: is patient safety compromised by treatment based solely on numerical pain ratings? Anesth Analg (2005) 2.83
Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc (2007) 2.82
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin (2007) 2.81
Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin (2003) 2.77
Counterpoint: Overdiagnosis in breast cancer screening. J Am Coll Radiol (2014) 2.75
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol (2009) 2.74
Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol (2003) 2.71
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ (2009) 2.68
Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer Discov (2011) 2.66
A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst (2005) 2.60
The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol (2007) 2.52
Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol (2008) 2.51
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst (2005) 2.47
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol (2012) 2.45
Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer (2008) 2.41
Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J (2014) 2.37
American Cancer Society Guidelines for the Early Detection of Cancer, 2005. CA Cancer J Clin (2005) 2.35
Sequential design approaches for bioequivalence studies with crossover designs. Pharm Stat (2008) 2.33
Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer (2008) 2.28
CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol (2007) 2.27
Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol (2007) 2.27
American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin (2004) 2.23
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med (2010) 2.17
Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers. Hum Pathol (2013) 2.09
Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology (2010) 2.06
Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med (2003) 2.05
External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis (2002) 2.05
Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One (2013) 2.03
Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med (2003) 1.97
2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis (2007) 1.90
Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer (2008) 1.90
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2006) 1.89
Factors that influence the rate of epithelial maturation in the cervix in healthy young women. J Adolesc Health (2009) 1.89
The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards. J Clin Oncol (2009) 1.88
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer (2002) 1.87
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J (2006) 1.85
Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial. Am J Obstet Gynecol (2005) 1.83
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res (2010) 1.82